3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Stage IB Cervical Cancer FIGO 2018
1
Spondylitis, Ankylosing
1
Psoriasis
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Melanoma
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Gastritis, Atrophic
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Transitional Cell
1
Cancer Care Recipient
1
Cancer Awareness and Prevention Education
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Arthritis, Psoriatic
1
Interventions
atezolizumab
5
avelumab
4
erdafitinib
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Immunotherapy
1
Histocompatibility Testing
1
High-Throughput Nucleotide Sequencing
1
Hematologic Tests
1
Gemcitabine
1
Focus Groups
1
Educational Status
1
Drug Therapy
1
Defecation
1
Cytological Techniques
1
Cystoscopy
1
Cisplatin
1
Carboxylesterase
1
Blood Cell Count
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Transitional Cell
×
Educational Status
×
Clear all
NCT05154084
2023-11-14
RESECT
British Urology Researchers in Surgical Training
Completed
19,505 enrolled